M. Borzio et al., LIVER-CELL DYSPLASIA IS A MAJOR RISK FACTOR FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A PROSPECTIVE-STUDY, Gastroenterology, 108(3), 1995, pp. 812-817
Background/Aims: In humans, the role of liver cell dysplasia as a pren
eoplastic lesion is still debated. A prospective, long-term, multicent
er study was performed to establish whether liver cell dysplasia in ci
rrhosis is associated with an increased risk for hepatocellular carcin
oma (HCC). Methods: A cohort of 307 consecutive patients in whom liver
cirrhosis was diagnosed by histology was investigated for development
of HCC at 6-month intervals by ultrasonography and determination of a
lpha-fetoprotein levels. Results: At enrollment, liver cell dysplasia
was found in 75 patients (24%) and in 53% (P < 0.01) of those positive
for hepatitis B surface antigen (HBsAg). After a mean follow-up of 46
months, HCC was detected in 45 cases, and it was significantly more f
requent in patients with liver cell dysplasia (P < 0.01) and HBsAg-ser
um positivity (P < 0.01). Multivariate analysis showed that liver cell
dysplasia was the most important risk factor correlated with HCC deve
lop ment. HBsAg positivity and age over 60 years were also independent
risk factors for HCC. Conclusions: These results indicate that liver
cell dysplasia is a major risk factor for HCC, and it should be looked
for carefully by pathologists in liver biopsy specimens to identify p
atients requiring more intensive observation.